Rocky Mountain MS Clinic and Research Group Publications and Presentations

› Natalizumab discontinuation predisposes to serious infusion related reactions and antibody formation

Foley JF

Sep 29, 2014 - Sep 29, 2014, Americas Committee for Treatment and Research in Multiple Sclerosis Annual Meeting (ACTRIMS): Emerg

› A management method for natalizumab administration

Menning K, Roy M, Foley JF

Consortium of Multiple Sclerosis Centers Annual Meeting

Sep 29, 2014 - Sep 29, 2014

› The Efficacy of Natalizumab in Patients with Relapsing Multiple Sclerosis in a Clinical Practice Setting

Foley JF

61st Annual Meeting of the American Academy of Neurology

Sep 29, 2014 - Sep 29, 2014, Seattle, Washington. April 29, 2009

› CD 4 dynamics in a natalizumab treated population

Foley JF

European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)

Sep 29, 2014 - Sep 29, 2014, Göteberg, Sweden, October 2010